Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature. (15th June 2020)

• Record Type: Journal Article
• Authors: Essa, Amr; Macaraeg, Jeffrey; Jagan, Nikhil; Kwon, Daniel; Randhawa, Saboor; Kruse, Matthew; Thomas, Stanley; Velagapudi, Manasa; Horne, John; Narechania, Shraddha; Kaster, Michael; Valenta, Carrie; Sahasranaman, Venketraman; Moore, Douglas
• Other Names: Terashima Takeshi Academic Editor.
• Is Part Of: Case reports in pulmonology. Volume 2020(2020)
• Publication Date: 2020-06-15
• Subjects: Lungs -- Diseases -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory infections -- Periodicals; Lung Diseases; Respiratory Tract Diseases; Respiratory Tract Infections; Lungs -- Diseases; Respiratory infections; Respiratory organs -- Diseases; Periodicals; Case Reports; Electronic journals; Periodicals; 616.2
• DOI: 10.1155/2020/1090629
• Languages: English
• ISSNs: 2090-6846

Abstract

Abstract : Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.